Mersana Therapeutics Inc (MRSN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -55,964 | -48,419 | -24,123 | -69,192 | -55,075 |
| Depreciation Amortization | 546 | 463 | 176 | -2,289 | -2,107 |
| Accounts receivable | -168 | -266 | N/A | N/A | -1,000 |
| Accounts payable and accrued liabilities | -1,937 | -1,407 | 44 | -2,857 | -5,154 |
| Other Working Capital | -6,737 | -9,453 | -8,231 | -27,622 | -19,249 |
| Other Operating Activity | 9,140 | 7,154 | 2,808 | 19,620 | 19,496 |
| Operating Cash Flow | $-55,120 | $-51,928 | $-29,326 | $-82,340 | $-63,089 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | 767 | 395 | N/A | -132 | -132 |
| Purchase Of Investment | 0 | 0 | 0 | -133,431 | -133,431 |
| Sale Of Investment | 27,000 | 27,000 | 27,000 | 145,000 | 95,000 |
| Investing Cash Flow | $27,767 | $27,395 | $27,000 | $11,437 | $-38,563 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -24,035 | -6,274 | -3,137 | -2,230 | -135 |
| Common Stock Issued | 0 | 0 | 0 | 56 | 56 |
| Common Stock Repurchased | 29 | 29 | N/A | 486 | 258 |
| Other Financing Activity | 0 | 0 | 0 | 5,780 | 5,780 |
| Financing Cash Flow | $-24,006 | $-6,245 | $-3,137 | $4,092 | $5,959 |
| Beginning Cash Position | 108,228 | 108,228 | 108,228 | 175,039 | 175,039 |
| End Cash Position | 56,869 | 77,450 | 102,765 | 108,228 | 79,346 |
| Net Cash Flow | $-51,359 | $-30,778 | $-5,463 | $-66,811 | $-95,693 |
| Free Cash Flow | |||||
| Operating Cash Flow | -55,120 | -51,928 | -29,326 | -82,340 | -63,089 |
| Capital Expenditure | 0 | 0 | 0 | -132 | -132 |
| Free Cash Flow | -55,120 | -51,928 | -29,326 | -82,472 | -63,221 |